Literature DB >> 16036174

Non-sleep effects of hypocretin/orexin.

Willis K Samson1, Meghan M Taylor, Alastair V Ferguson.   

Abstract

Although a role for hypocretin/orexin (HCT/ORX) in sleep/wakefulness and arousal is widely recognized, other actions, not necessarily related to sleep, have been identified. Neurons producing the peptides project to brain sites known to be important in neuroendocrine and autonomic function, as well as appetite regulation. There is consensus that HCT/ORX plays a role in the regulation of cardiovascular function via its effects on sympathetic nervous activity, and the reported pharmacologic effects have been demonstrated to be physiologically relevant. Equally provocative are the actions of these peptides in the hypothalamus and pituitary gland to regulate reproductive and stress hormone secretion. While HCT/ORX are less potent stimulators of food intake than other hypothalamic peptides, HCT/ORX may play an integral role in the organization of hunger and satiation behaviors because of their interaction with those other peptides. In fact recent discoveries of interactions of HCT/ORX with peptides such as corticotropin releasing hormone and neuropeptide Y, as well as with aminergic neurotransmitter systems, are now defining the cellular and molecular mechanisms by which these potent neuropeptides act and promise insight into their physiologic relevance in a variety of non-sleep related behaviors and other homeostatic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036174     DOI: 10.1016/j.smrv.2004.07.006

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  18 in total

1.  Altered sleep-related blood pressure profile in hypocretin-deficient narcoleptic patients.

Authors:  Yves Dauvilliers
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

3.  Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy.

Authors:  Yves Dauvilliers; Marie-Hélène Pennestri; Shirley Whittom; Paola A Lanfranchi; Jacques Y Montplaisir
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

4.  GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus.

Authors:  Xinmin Xie; Tara L Crowder; Akihiro Yamanaka; Stephen R Morairty; Robin D Lewinter; Takeshi Sakurai; Thomas S Kilduff
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

Review 5.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 6.  Associations between sleep loss and increased risk of obesity and diabetes.

Authors:  Kristen L Knutson; Eve Van Cauter
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 7.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

8.  Orexin signaling mediates the antidepressant-like effect of calorie restriction.

Authors:  Michael Lutter; Vaishnav Krishnan; Scott J Russo; Saendy Jung; Colleen A McClung; Eric J Nestler
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

9.  High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study.

Authors:  Hal A Droogleever Fortuyn; Sofie Swinkels; Jan Buitelaar; Wily O Renier; Joop W Furer; Cees A Rijnders; Paul P Hodiamont; Sabastiaan Overeem
Journal:  Sleep       Date:  2008-03       Impact factor: 5.849

Review 10.  Sleep and the epidemic of obesity in children and adults.

Authors:  Eve Van Cauter; Kristen L Knutson
Journal:  Eur J Endocrinol       Date:  2008-08-21       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.